Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.

[1]  J. Ledermann,et al.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.

[2]  E. Lengyel,et al.  Patterns and utility of routine surveillance in high grade endometrial cancer. , 2015, Gynecologic oncology.

[3]  C. Coutant,et al.  Just how accurate are the major risk stratification systems for early-stage endometrial cancer? , 2015, British Journal of Cancer.

[4]  A. Althouse,et al.  USA endometrial cancer projections to 2030: should we be concerned? , 2014, Future oncology.

[5]  S. Rose,et al.  Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer. , 2014, Gynecologic oncology.

[6]  B. Weigelt,et al.  Classification of endometrial carcinoma: more than two types. , 2014, The Lancet. Oncology.

[7]  C. Coutant,et al.  A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion , 2014, British Journal of Cancer.

[8]  Kathleen R. Cho,et al.  Uterine neoplasms, version 1.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  R. Barakat,et al.  Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment , 2013, International Journal of Gynecologic Cancer.

[10]  R. Gelber,et al.  Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Richard G. Moore,et al.  Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. , 2013, Gynecologic oncology.

[12]  A. Mariani,et al.  Patterns of Recurrence in Stage I Endometrioid Endometrial Adenocarcinoma With Lymphovascular Space Invasion , 2013, International Journal of Gynecologic Cancer.

[13]  M. Kattan,et al.  Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. , 2012, Gynecologic oncology.

[14]  L. Landrum,et al.  Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? , 2012, Gynecologic Oncology.

[15]  E. Anteby,et al.  Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  F Landoni,et al.  Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  C. Haie-meder,et al.  Clinical Practice Guidelines for the Management of Patients With Endometrial Cancer in France: Recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique , 2011, International Journal of Gynecologic Cancer.

[18]  A. Gadducci,et al.  Surveillance Procedures for Patients Treated for Endometrial Cancer: A Review of the Literature , 2010, International Journal of Gynecologic Cancer.

[19]  H. Putter,et al.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.

[20]  S. Pecorelli.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[21]  T. Oliver,et al.  Follow-up after primary therapy for endometrial cancer: a systematic review. , 2006, Gynecologic oncology.

[22]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[23]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.

[24]  J. Sorosky,et al.  Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. , 1992, Gynecologic oncology.

[25]  J. V. Bokhman.  Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.

[26]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[27]  C. Coutant,et al.  External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study. , 2015, American journal of obstetrics and gynecology.

[28]  B. Glimelius,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.